Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant512 active trials34 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,118 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06299891 | Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity | recruiting | Phase 2 | 24 | Seattle Children's HospitalOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT03890952 | Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma | completed | Phase 2 | 40 | Ulrik LassenOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT04135807 |
| Implantable Microdevice In Primary Brain Tumors |
| recruiting |
| Early Phase 1 |
| 12 |
| Oliver JonasOTHER |
| 1 |
| Jul 23, 2025 |
| clinicaltrials |
| NCT01843413 | Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases | active not recruiting | Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT04410367 | Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)(PURSUE) | completed | Phase 2 | 23 | Blue Earth DiagnosticsINDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT04474925 | Pre- Versus Post-operative SRS for Resectable Brain Metastases | terminated | Phase 3 | 8 | AHS Cancer Control AlbertaOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT06501521 | Non-invasive Brain Tumor Molecular Diagnostics and Monitoring | recruiting | — | 200 | The Institute of Molecular and Translational Medicine, Czech RepublicOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT03731455 | WISE Cortical Strip for Intraoperative Neurophysiological Monitoring(WIN) | completed | N/A | 32 | Wise S.r.l.INDUSTRY | 3 | Jul 17, 2025 | clinicaltrials |
| NCT04239092 | 9-ING-41 in Pediatric Patients With Refractory Malignancies. | terminated | Phase 1 | 40 | Actuate Therapeutics Inc.INDUSTRY | 1 | Jul 17, 2025 | clinicaltrials |
| NCT06092125 | Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease(CAMIND) | recruiting | — | 2,300 | Xuanwu Hospital, BeijingOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06457906 | SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC(SHARP) | recruiting | Phase 3 | 340 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06099743 | ASCENT Intervention for Brain Tumor Patients | recruiting | N/A | 100 | Massachusetts General HospitalOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT06128148 | Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors(JYP0322) | recruiting | Phase 1 | 101 | Guangzhou JOYO Pharma Co., LtdINDUSTRY | 1 | Jul 14, 2025 | clinicaltrials |
| NCT03893487 | Fimepinostat in Treating Brain Tumors in Children and Young Adults(PNOC016) | active not recruiting | Early Phase 1 | 30 | Sabine Mueller, MD, PhDOTHER | 2 | Jul 11, 2025 | clinicaltrials |
| NCT05169944 | Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors(PNOC025) | completed | Phase 1 | 13 | University of California, San FranciscoOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07049094 | The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy | recruiting | Phase 4 | 218 | Zhejiang UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07046481 | Physical Activity and Quality of Life in Childhood Cancersurvivors- a Long-term Follow-up | withdrawn | N/A | 0 | Region SkaneOTHER | 0 | Jul 1, 2025 | clinicaltrials |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors(SPARTA) | recruiting | Phase 2 | 497 | Apollomics Inc.INDUSTRY | 11 | Jun 27, 2025 | clinicaltrials |
| NCT04461418 | Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases(ACT-FAST) | terminated | Phase 2 | 2 | AHS Cancer Control AlbertaOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT02514915 | Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases | completed | N/A | 24 | Christopher WilkeOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT06896110 | Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma | enrolling by invitation | Phase 1 | 34 | Andrew P. GrovesOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT07034859 | Cabergoline in the Management of Nonfunctioning Pituitary Adenoma | enrolling by invitation | Phase 4 | 30 | National Taiwan University HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT04111588 | Diagnostic Assessment of Amino Acid PET/MRI in the Evaluation of Glioma and Brain Metastases | recruiting | — | 160 | Norwegian University of Science and TechnologyOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT04320108 | ESWT for Shoulder Pain in Patients With Brain Damage | completed | N/A | 6 | Bundang CHA HospitalOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT06951659 | Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours | recruiting | — | 100 | The University of Western AustraliaOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT02667587 | An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)(CheckMate548) | completed | Phase 3 | 716 | Bristol-Myers SquibbINDUSTRY | 19 | Jun 18, 2025 | clinicaltrials |
| NCT04734444 | SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue | completed | N/A | 45 | SonoClear ASINDUSTRY | 3 | Jun 17, 2025 | clinicaltrials |
| NCT05620914 | A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases(PARAMETer) | withdrawn | Phase 2 | 0 | Mustafa Khasraw, MBChB, MD, FRCP, FRACPOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT03567486 | Predictive Factors of Visual Recovery After Paraoptic Tumors Removal(PRONOPTIC) | completed | — | 99 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 1 | Jun 11, 2025 | clinicaltrials |
| NCT04785521 | Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery | active not recruiting | — | 100 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT05831631 | Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors | recruiting | — | 200 | Pietro Mortini, MD, Prof.OTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06263361 | Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma. | recruiting | — | 15 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT04804709 | Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG) | terminated | Phase 1 | 5 | Columbia UniversityOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05822817 | Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery | completed | Phase 4 | 252 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT04749641 | Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma(ENACTING) | completed | Phase 1 | 16 | Yang ZhangOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT04847284 | Intraoperative Radiotherapy in Patients With Brain Metastases | recruiting | N/A | 25 | Parc de Salut MarOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT04479241 | LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma | completed | Phase 2 | 25 | Istari Oncology, Inc.INDUSTRY | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06494046 | Defining Musical Toxicity and Its Effect on Patient Well-being | withdrawn | — | 0 | Mayo ClinicOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT01288235 | Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation | completed | Phase 2 | 100 | Massachusetts General HospitalOTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT06992973 | Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases | recruiting | N/A | 98 | Regina Elena Cancer InstituteOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT03047473 | Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme(SEJ) | completed | Phase 2 | 38 | Clinique Neuro-OutaouaisOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT03898908 | Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain(EBRAIN-MEL) | completed | Phase 2 | 48 | Grupo Español Multidisciplinar de MelanomaOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT01703507 | Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma | completed | Phase 1 | 17 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04468919 | Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit(BCI-FIT) | completed | N/A | 55 | Oregon Health and Science UniversityOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT05477680 | Intraoperative Brain Shift Calculation Study(BRASH) | recruiting | N/A | 100 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT05484219 | Functional Navigation in Surgery of Cerebral Tumors and Vascular Malformations(FUN) | suspended | N/A | 50 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT05484245 | Sonography-guided Resection of Brain Mass Lesions(SOMALI) | recruiting | N/A | 100 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT06973824 | A Twenty-years' Experience in Pituitary Disease.(TYEPDD) | recruiting | — | 1,600 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT03665545 | Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma(IMA950-106) | completed | Phase 1 / Phase 2 | 18 | University Hospital, GenevaOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT05397873 | Biofeedback for Hemianopia Vision Rehabilitation | recruiting | N/A | 32 | University Health Network, TorontoOTHER | 1 | May 9, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2025source: clinicaltrials